New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
07:16 EDTOPHTOphthotech price target raised to $45 from $37 at Leerink
Leerink raised its price target for Ophthotech shares to $45 citing Fovista and Zimura pipeline advancement. The firm reiterates an Outperform rating on the stock.
News For OPHT From The Last 14 Days
Check below for free stories on OPHT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
07:32 EDTOPHTOphthotech announces Fovista Phase 2b trial presentation
Subscribe for More Information
September 9, 2014
07:55 EDTOPHTOphthotech earlier than expected Novartis payment positive, says Oppenheimer
After Ophthotech (OPHT) received a $50M Phase 3 enrollment payment from Novartis (NVS) earlier than expected, Oppenheimer thinks the payment highlights an underappreciated stock driver for Opthotech, and demonstrates that recent suggestions of Phase 3 enrollment timelines possibly slipping are unwarranted. The firm believes the company is executing well on the Fovista Phase 3 program and keeps an Outperform rating on the stock.
September 8, 2014
07:33 EDTOPHTOphthotech achieves $50M milestone under ex-agreement with Novartis for Fovista
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use